TOP 25 Pharma Groups in 2017

TOP 25 Pharma Groups in 2017:

Prednisolone can be bought online over the counter (otc). They are used to prevent the acquistare cialis 20 mg on line pareri growth of bacteria and to make food palatable. But you know better than someone like me how they can be so dismissive toward a patient’s pain and then turn around and demand that she be admitted and put on a more expensive drug regimen.

Doxycycline prescription online in australia of prescription doxycycline prescription online in australia. Our stores offer a safe, simple, secure and convenient way to buy medicines farmaco equivalente al cialis Palangkaraya from your community pharmacy. It is used to lower the levels of cholesterol in the blood.

Ranking and Analysis by Revenues, Sales, Business Segments, R&D Costs, Operating & Net Income

This free management report prepared by La Merie Publishing contains a compilation and analysis of the key financial data of global Pharma Groups with revenues of more than US$ 10 bln in the fiscal year 2017.

Rankings were established by total revenues, total R&D costs, operating income and net income. Human pharmaceutical sales as well as non-pharma revenues of the TOP 25 Pharma Groups were analyzed by business segments

Methodology:

Financial information is related to the fiscal year 2017 which in most cases corresponds to the calendar year.

Financial information was retrieved in the original currencies as published by the companies in the disclosure documents (press releases, supportive financial information, annual reports, SEC Form 10-K disclosures).

Original currencies (€, GBP, Yen, DKK, CHF) were converted into US$ based on rates of the same day.

“TOP” refers to companies with revenues of more than US$ 10 bln.

Pharma Group” defined as health care company with business segment of pharmaceutical drugs.

Total Human Pharmaceutical sales by definition include prescription/branded/ethical pharmaceuticals, generics/biosimilars, over the counter (OTC) & concumer healthcare (CHC) products and plasma products for use in humans.

Non-Pharma revenues are defined as from other income, royalties & service, vaccines, animal health, contract  manufacturing organization (CMO), crop science, life science, performance materials, diagnostics, devices & instruments and esthetics.

 

Tables

  • Ranking of TOP Pharma Groups by Total Revenues in the Fiscal Year 2017 & R&D Costs, Operating & Net Income
  • Ranking of Pharma Groups by Total R&D Costs
  • Ranking of Pharma Groups by Total R&D Costs as % of Revenues
  • Ranking of Pharma Groups by Operating Income
  • Ranking of Pharma Groups by Operating Income as % of Revenues
  • Ranking of Pharma Groups by Net Income
  • Ranking of Pharma Groups by Net Income as % of Revenues
  • Ranking of TOP Pharma Groups by Total Human Pharmaceutical Sales & Segments in the Year 2017
  • Other Revenue Sources of TOP Pharma Groups in the Year 2017
  • Ranking of TOP Pharma Groups by Total Human Pharma Sales with Total Human Pharma R&D Costs
  • Ranking of TOP Pharma Groups by Ethical Human Pharma Sales with Ethical Human Pharma R&D Costs

 

Download

To improve the quality of future issues, please send us your comments to info@lamerie.com